CoreAxis Labs
Clinical risk intelligence for fast, evidence-based R&D decisions.
Unified insights from multimodal biomedical signals — clinical failure patterns, mechanism toxicity, regulatory deviations, and emerging literature — automatically synthesized into one actionable intelligence layer.
Updated automatically — includes MoA risk clusters, trial termination trends, regulatory exposure, and dynamic risk scoring across 1M+ biomedical signals.
Core Intelligence Layers
Mechanism Risk
MoA-specific toxicity propagation, cross-portfolio risk clusters, and failure-aligned target signatures.
Clinical Attrition
Phase-aligned failure rates, terminated/withdrawn trial patterns, and competitor movement analytics.
Regulatory Exposure
FDA 21 CFR deviations — sterility, GMP failures, labeling issues, and manufacturing-quality alerts.
Featured Insights
Mechanism-Aligned Failure Clusters
DNA-aligned toxicity, tubulin-linked failure propagation, and immunology cross-risk patterns detected across hundreds of MoAs.
Open Report →
High-Risk Drug Portfolio Overview
Dynamic risk scoring, reasoning summaries, and mitigation strategies across oncology, immunology, and metabolic portfolios.
Open Report →
Powered by 1M+ Evidence Signals
Our engine integrates disease–target relations, MoA failure alignment, DepMap essentiality, bioactivity matrices, PubMed surge tracking, and global regulatory deviations — enabling rapid, accurate, and strategic decision-making across the entire R&D pipeline.
1M+ Signals
Biomedical evidence sources continuously updated.
Automatic Analysis
Daily regeneration ensures real-time intelligence.
Decision-Ready
Concise insights for R&D, BD, and clinical strategy teams.